Subgroup Analyses of Visual Acuity Outcomes in the CRUISE Study of Intravitreal Ranibizumab in Patients with Macular Edema Following Central Retinal Vein Occlusion

被引:0
|
作者
Regillo, C. D. [1 ]
Rubio, R. [2 ]
Saroj, N. [2 ]
Li, Z. [2 ]
Rundle, A. [2 ]
Gray, S. [2 ]
Murahashi, W. Yee [2 ]
机构
[1] Wills Eye Inst, Retina Serv, Philadelphia, PA USA
[2] Genentech Inc, San Francisco, CA 94080 USA
关键词
vascular occlusion/vascular occlusive disease; edema; vascular endothelial growth factor;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3566
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion in Patients with Prior Treatment with Bevacizumab or Ranibizumab
    van Zyl, Tave
    Papakostas, Thanos D.
    Lim, Laurence Shen
    Miller, John B.
    Husain, Deeba
    Eliott, Dean
    Kim, Leo A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [22] Short-term prospective study of intravitreal ranibizumab for macular edema secondary to central retinal vein occlusion
    Tsuiki, Eiko
    Suzuma, Kiyoshi
    Matsumoto, Makiko
    Kitaoka, Takashi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [23] Intravitreal Ranibizumab and/or Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion
    Nghiem-Buffet, Sylvia
    Fajnkuchen, Franck
    Buffet, Marc
    Ayrault, Sandrine
    Le Gloahec-Lorcy, Anna
    Grenet, Typhaine.
    Delahaye-Mazza, Corinne
    Quentel, Gabriel
    Cohen, Salomon Y.
    OPHTHALMOLOGICA, 2014, 232 (04) : 216 - 222
  • [24] Twenty-Four Month Results of Intravitreal Ranibizumab for Macular Edema after Branch Retinal Vein Occlusion: Visual Outcomes and Resolution of Macular Edema
    Inagaki, Miho
    Hirano, Yoshio
    Yasuda, Yusuke
    Kawamura, Mihoko
    Suzuki, Norihiro
    Yasukawa, Tsutomu
    Yoshida, Munenori
    Ogura, Yuichiro
    SEMINARS IN OPHTHALMOLOGY, 2021, 36 (07) : 482 - 489
  • [25] Cytokines and Recurrence of Macular Edema after Intravitreal Ranibizumab in Patients with Branch Retinal Vein Occlusion
    Noma, Hidetaka
    Mimura, Tatsuya
    Yasuda, Kanako
    Nakagawa, Hayate
    Motohashi, Ryosuke
    Kotake, Osamu
    Shimura, Masahiko
    OPHTHALMOLOGICA, 2016, 236 (04) : 228 - 234
  • [26] Pharmacokinetics of Ranibizumab after Intravitreal Administration in Patients with Retinal Vein Occlusion or Diabetic Macular Edema
    Zhang, Yi
    Yao, Zhenling
    Kaila, Nitin
    Kuebler, Peter
    Visich, Jennifer
    Maia, Mauricio
    Tuomi, Lisa
    Ehrlich, Jason S.
    Rubio, Roman G.
    Campochiaro, Peter A.
    OPHTHALMOLOGY, 2014, 121 (11) : 2237 - 2246
  • [27] The Efficacy of Intravitreal Ranibizumab and Dexamethasone Implant in Macular Edema Secondary to Branch and Central Retinal Vein Occlusion
    Yucel, Ozlem Eski
    Niyaz, Leyla
    Sullu, Yuksel
    Birinci, Hakki
    OPHTHALMOLOGICA, 2014, 232 : 94 - 94
  • [28] LONGER-TERM OUTCOMES OF A PROSPECTIVE STUDY OF INTRAVITREAL RANIBIZUMAB AS A TREATMENT FOR DECREASED VISUAL ACUITY SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
    Chang, Louis K.
    Spaide, Richard F.
    Klancnik, James M.
    Sorenson, John
    Slakter, Jason S.
    Freund, K. Bailey
    Yannuzzi, Lawrence A.
    Tseng, Joseph J.
    Klein, Robert
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (05): : 821 - 828
  • [29] Visual acuity and optical coherence tomographic outcomes following intravitreal triamcinolone acetonide injection for macular edema associated with branch retinal vein occlusion
    Scott, IU
    Cruz-Villegas, V
    Flynn, HW
    Puliafito, CA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U743 - U743
  • [30] Macular Function in Macular Edema Associated with Branch Retinal Vein Occlusion Treated with Intravitreal Ranibizumab
    Nishimura, Tomoharu
    Machida, Shigeki
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)